Cytokeratin 5–Positive Cells Represent a Therapy Resistant subpopulation in Epithelial Ovarian Cancer

No abstract is available for this paper.

• Publication year

  2015

• Venue

  International Journal of Gynecologic Cancer

• Publication date

  2015-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1097/IGC.0000000000000553PMID 26495758PMCID PMC4635519
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cancer statistics, 2014

  2014cited by this paper
• Ovarian cancer stem cells: are they real and why are they important?

  2014cited by this paper
• Hormonal Treatment in Recurrent and Metastatic Gynaecological Cancers: A Review of the Current Literature

  2013cited by this paper
• Emerging role of cancer stem cells in the biology and treatment of ovarian cancer: basic knowledge and therapeutic possibilities for an innovative approach

  2013cited by this paper
• Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study.

  2013cited by this paper
• Potential Role of Estrogen Receptor Beta as a Tumor Suppressor of Epithelial Ovarian Cancer

  2012cited by this paper
• Cancer stem cells: an evolving concept

  2012cited by this paper
• Cancer stem cells: impact, heterogeneity, and uncertainty.

  2012cited by this paper
• Integrated Genomic Analyses of Ovarian Carcinoma

  2011cited by this paper
• Cytokeratin 5 positive cells represent a steroid receptor negative and therapy resistant subpopulation in luminal breast cancers

  2011cited by this paper
• Stem Cell Pathways Contribute to Clinical Chemoresistance in Ovarian Cancer

  2011cited by this paper
• Phenotypic heterogeneity and instability of human ovarian tumor-initiating cells

  2011cited by this paper
• Tumor heterogeneity: causes and consequences.

  2010cited by this paper
• Tamoxifen for relapse of ovarian cancer.

  2010cited by this paper
• Pegylated liposomal Doxorubicin and Carboplatin compared with Paclitaxel and Carboplatin for patients with platinum-sensitive ovarian cancer in late relapse.

  2010cited by this paper
• BRCA1 basal-like breast cancers originate from luminal epithelial progenitors and not from basal stem cells.

  2010cited by this paper
• Tissue-specific pathways for estrogen regulation of ovarian cancer growth and metastasis.

  2010cited by this paper
• A phase II study of fulvestrant in the treatment of multiply-recurrent epithelial ovarian cancer.

  2009cited by this paper
• Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers

  2009influential reference
• Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature.

  2009cited by this paper
• Rare steroid receptor-negative basal-like tumorigenic cells in luminal subtype human breast cancer xenografts

  2008cited by this paper
• Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy

  2008cited by this paper
• The CD44+/CD24- phenotype is enriched in basal-like breast tumors

  2008cited by this paper
• ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome.

  2007cited by this paper
• Cancer as an evolutionary and ecological process

  2006cited by this paper
• Estrogen receptor-alpha mediates gene expression changes and growth response in ovarian cancer cells exposed to estrogen.

  2005cited by this paper
• Basal cytokeratins and their relationship to the cellular origin and functional classification of breast cancer

  2005cited by this paper
• The Catalog of Human Cytokeratins: Patterns of Expression in Normal Epithelia, Tumors and Cultured Cells Review

  2004cited by this paper
• In vitro culturing and characteristics of transit amplifying epithelial cells from human prostate tissue

  2004cited by this paper
• Prospective identification of tumorigenic breast cancer cells

  2003cited by this paper
• Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial.

  2003cited by this paper
• Expression of Cytokeratin 5/6 in Epithelial Neoplasms: An Immunohistochemical Study of 509 Cases

  2002cited by this paper
• CA125 response is associated with estrogen receptor expression in a phase II trial of letrozole in ovarian cancer: identification of an endocrine-sensitive subgroup.

  2002cited by this paper
• Common Adult Stem Cells in the Human Breast Give Rise to Glandular and Myoepithelial Cell Lineages: A New Cell Biological Concept

  2002cited by this paper
• Stem cells, cancer, and cancer stem cells

  2001cited by this paper
• Tamoxifen for relapse of ovarian cancer.

  2001cited by this paper
• SKOV3 ovarian carcinoma cells have functional estrogen receptor but are growth-resistant to estrogen and antiestrogens.

  1995cited by this paper
• Cancer of the ovary.

  1994cited by this paper
• Cancer of the ovary.

  1993cited by this paper
• Endocrine factors in common epithelial ovarian cancer.

  1991cited by this paper
• Cancer statistics

  1989cited by this paper
• Characterization and properties of nine human ovarian adenocarcinoma cell lines.

  1988cited by this paper
• Characterization of a human ovarian carcinoma cell line (NIH:OVCAR-3) with androgen and estrogen receptors.

  1983cited by this paper
• The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells.

  1982cited by this paper

• Keratin 5 marks cancer-propagating cells sustained by an osteopontin-producing niche in high-grade serous ovarian carcinoma

  2026cites this paper
• Cell-intrinsic platinum response and associated genetic and gene expression signatures in ovarian cancer cell lines and isogenic models

  2024cites this paper
• Cytokeratin Expression Pattern in Human Endometrial Carcinomas and Lymph Nodes Micrometastasis: a Mini-review

  2022cites this paper
• Estrogen- and estrogen receptor (ER)-mediated cisplatin chemoresistance in cancer.

  2021cites this paper
• Stem cells in breast milk

  2018cites this paper
• Circulating tumor cells: potential markers of minimal residual disease in ovarian cancer? a study of the OVCAD consortium

  2017cites this paper
• Keratin 5 overexpression is associated with serous ovarian cancer recurrence and chemotherapy resistance

  2017cites this paper
• Cytokeratin 5/6 expression, prognosis, and association with estrogen receptor α in high-grade serous ovarian carcinoma.

  2017influential citation
• PUBLISHED VERSION

  2017cites this paper
• 2015 Publications of the Baylor Scott & White Health North Division Medical and Scientific Staff

  2016cites this paper
• Partial Oxygen Pressure Affects the Expression of Prognostic Biomarkers HIF-1 Alpha, Ki67, and CK20 in the Microenvironment of Colorectal Cancer Tissue

  2016cites this paper